Melanie Blevins

Affiliations: 
2008 Medicinal Chemistry University of Kansas, Lawrence, KS, United States 
Google:
"Melanie Blevins"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhou H, Blevins MA, Hsu JY, et al. (2020) A SIX1/EYA2 small molecule inhibitor disrupts EMT and metastasis. Cancer Research
Zhou H, Blevins M, Kong D, et al. (2020) Novel Small Molecule Compound disrupts the SIX1/EYA2 Complex and Inhibits Breast Cancer Metastasis The Faseb Journal. 34: 1-1
Anantharajan J, Zhou H, Zhang L, et al. (2019) Structural and functional analyses of an allosteric Eya2 phosphatase inhibitor that has on target effects in human lung cancer cells. Molecular Cancer Therapeutics
Zhou H, Blevins M, Zhang L, et al. (2019) Abstract 2004: Identification of a novel small molecule inhibitor of the Six1/Eya2 complex andin vivometastasis Cancer Research
Blevins MA, Huang M, Zhao R. (2017) The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target. Molecular Cancer Therapeutics. 16: 981-990
Blevins MA, Towers CG, Patrick AN, et al. (2015) The SIX1-EYA transcriptional complex as a therapeutic target in cancer. Expert Opinion On Therapeutic Targets. 19: 213-25
Blevins MA, Kouznetsova J, Krueger AB, et al. (2015) Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression. Journal of Biomolecular Screening. 20: 663-72
Krueger AB, Drasin DJ, Lea WA, et al. (2014) Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration. The Journal of Biological Chemistry. 289: 16349-61
Patrick A, Blevins M, Krueger A, et al. (2013) Abstract B102: Targeting the SIX1/EYA transcriptional complex as a potential anti-cancer therapy. Molecular Cancer Therapeutics. 12
Blevins M, An J, Jones S, et al. (2011) Abstract 1373: Identification of potential anti-tumor therapeutics targeting the Six1 transcriptional complex Cancer Research. 71: 1373-1373
See more...